[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vaginosis Drug Market Growth 2022-2028

March 2022 | 114 pages | ID: G9B27908157EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Vaginosis Drug will have significant change from previous year. According to our (LP Information) latest study, the global Vaginosis Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vaginosis Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Vaginosis Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vaginosis Drug market, reaching US$ million by the year 2028. As for the Europe Vaginosis Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Vaginosis Drug players cover Bayer, Pfizer, Sanofi, and Piramal, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaginosis Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Rx
  • OTC
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Hospital
  • Pharmacy
  • Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Bayer
  • Pfizer
  • Sanofi
  • Piramal
  • Abbott
  • Galderma
  • Mission
  • Alkem
  • Xiuzheng
  • Teva
  • Perrigo
  • West-Ward
  • HPGC
  • Yunnan Baiyao
  • Starpharma
  • Novel
  • Edenvridge
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vaginosis Drug Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Vaginosis Drug by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Vaginosis Drug by Country/Region, 2017, 2022 & 2028
2.2 Vaginosis Drug Segment by Type
  2.2.1 Rx
  2.2.2 OTC
2.3 Vaginosis Drug Sales by Type
  2.3.1 Global Vaginosis Drug Sales Market Share by Type (2017-2022)
  2.3.2 Global Vaginosis Drug Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Vaginosis Drug Sale Price by Type (2017-2022)
2.4 Vaginosis Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmacy
  2.4.3 Other
2.5 Vaginosis Drug Sales by Application
  2.5.1 Global Vaginosis Drug Sale Market Share by Application (2017-2022)
  2.5.2 Global Vaginosis Drug Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Vaginosis Drug Sale Price by Application (2017-2022)

3 GLOBAL VAGINOSIS DRUG BY COMPANY

3.1 Global Vaginosis Drug Breakdown Data by Company
  3.1.1 Global Vaginosis Drug Annual Sales by Company (2020-2022)
  3.1.2 Global Vaginosis Drug Sales Market Share by Company (2020-2022)
3.2 Global Vaginosis Drug Annual Revenue by Company (2020-2022)
  3.2.1 Global Vaginosis Drug Revenue by Company (2020-2022)
  3.2.2 Global Vaginosis Drug Revenue Market Share by Company (2020-2022)
3.3 Global Vaginosis Drug Sale Price by Company
3.4 Key Manufacturers Vaginosis Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Vaginosis Drug Product Location Distribution
  3.4.2 Players Vaginosis Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR VAGINOSIS DRUG BY GEOGRAPHIC REGION

4.1 World Historic Vaginosis Drug Market Size by Geographic Region (2017-2022)
  4.1.1 Global Vaginosis Drug Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Vaginosis Drug Annual Revenue by Geographic Region
4.2 World Historic Vaginosis Drug Market Size by Country/Region (2017-2022)
  4.2.1 Global Vaginosis Drug Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Vaginosis Drug Annual Revenue by Country/Region
4.3 Americas Vaginosis Drug Sales Growth
4.4 APAC Vaginosis Drug Sales Growth
4.5 Europe Vaginosis Drug Sales Growth
4.6 Middle East & Africa Vaginosis Drug Sales Growth

5 AMERICAS

5.1 Americas Vaginosis Drug Sales by Country
  5.1.1 Americas Vaginosis Drug Sales by Country (2017-2022)
  5.1.2 Americas Vaginosis Drug Revenue by Country (2017-2022)
5.2 Americas Vaginosis Drug Sales by Type
5.3 Americas Vaginosis Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vaginosis Drug Sales by Region
  6.1.1 APAC Vaginosis Drug Sales by Region (2017-2022)
  6.1.2 APAC Vaginosis Drug Revenue by Region (2017-2022)
6.2 APAC Vaginosis Drug Sales by Type
6.3 APAC Vaginosis Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Vaginosis Drug by Country
  7.1.1 Europe Vaginosis Drug Sales by Country (2017-2022)
  7.1.2 Europe Vaginosis Drug Revenue by Country (2017-2022)
7.2 Europe Vaginosis Drug Sales by Type
7.3 Europe Vaginosis Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vaginosis Drug by Country
  8.1.1 Middle East & Africa Vaginosis Drug Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Vaginosis Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Vaginosis Drug Sales by Type
8.3 Middle East & Africa Vaginosis Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaginosis Drug
10.3 Manufacturing Process Analysis of Vaginosis Drug
10.4 Industry Chain Structure of Vaginosis Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Vaginosis Drug Distributors
11.3 Vaginosis Drug Customer

12 WORLD FORECAST REVIEW FOR VAGINOSIS DRUG BY GEOGRAPHIC REGION

12.1 Global Vaginosis Drug Market Size Forecast by Region
  12.1.1 Global Vaginosis Drug Forecast by Region (2023-2028)
  12.1.2 Global Vaginosis Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaginosis Drug Forecast by Type
12.7 Global Vaginosis Drug Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Bayer
  13.1.1 Bayer Company Information
  13.1.2 Bayer Vaginosis Drug Product Offered
  13.1.3 Bayer Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Bayer Main Business Overview
  13.1.5 Bayer Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Vaginosis Drug Product Offered
  13.2.3 Pfizer Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi Vaginosis Drug Product Offered
  13.3.3 Sanofi Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Piramal
  13.4.1 Piramal Company Information
  13.4.2 Piramal Vaginosis Drug Product Offered
  13.4.3 Piramal Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Piramal Main Business Overview
  13.4.5 Piramal Latest Developments
13.5 Abbott
  13.5.1 Abbott Company Information
  13.5.2 Abbott Vaginosis Drug Product Offered
  13.5.3 Abbott Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Abbott Main Business Overview
  13.5.5 Abbott Latest Developments
13.6 Galderma
  13.6.1 Galderma Company Information
  13.6.2 Galderma Vaginosis Drug Product Offered
  13.6.3 Galderma Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Galderma Main Business Overview
  13.6.5 Galderma Latest Developments
13.7 Mission
  13.7.1 Mission Company Information
  13.7.2 Mission Vaginosis Drug Product Offered
  13.7.3 Mission Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Mission Main Business Overview
  13.7.5 Mission Latest Developments
13.8 Alkem
  13.8.1 Alkem Company Information
  13.8.2 Alkem Vaginosis Drug Product Offered
  13.8.3 Alkem Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Alkem Main Business Overview
  13.8.5 Alkem Latest Developments
13.9 Xiuzheng
  13.9.1 Xiuzheng Company Information
  13.9.2 Xiuzheng Vaginosis Drug Product Offered
  13.9.3 Xiuzheng Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Xiuzheng Main Business Overview
  13.9.5 Xiuzheng Latest Developments
13.10 Teva
  13.10.1 Teva Company Information
  13.10.2 Teva Vaginosis Drug Product Offered
  13.10.3 Teva Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Teva Main Business Overview
  13.10.5 Teva Latest Developments
13.11 Perrigo
  13.11.1 Perrigo Company Information
  13.11.2 Perrigo Vaginosis Drug Product Offered
  13.11.3 Perrigo Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Perrigo Main Business Overview
  13.11.5 Perrigo Latest Developments
13.12 West-Ward
  13.12.1 West-Ward Company Information
  13.12.2 West-Ward Vaginosis Drug Product Offered
  13.12.3 West-Ward Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 West-Ward Main Business Overview
  13.12.5 West-Ward Latest Developments
13.13 HPGC
  13.13.1 HPGC Company Information
  13.13.2 HPGC Vaginosis Drug Product Offered
  13.13.3 HPGC Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 HPGC Main Business Overview
  13.13.5 HPGC Latest Developments
13.14 Yunnan Baiyao
  13.14.1 Yunnan Baiyao Company Information
  13.14.2 Yunnan Baiyao Vaginosis Drug Product Offered
  13.14.3 Yunnan Baiyao Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.14.4 Yunnan Baiyao Main Business Overview
  13.14.5 Yunnan Baiyao Latest Developments
13.15 Starpharma
  13.15.1 Starpharma Company Information
  13.15.2 Starpharma Vaginosis Drug Product Offered
  13.15.3 Starpharma Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.15.4 Starpharma Main Business Overview
  13.15.5 Starpharma Latest Developments
13.16 Novel
  13.16.1 Novel Company Information
  13.16.2 Novel Vaginosis Drug Product Offered
  13.16.3 Novel Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.16.4 Novel Main Business Overview
  13.16.5 Novel Latest Developments
13.17 Edenvridge
  13.17.1 Edenvridge Company Information
  13.17.2 Edenvridge Vaginosis Drug Product Offered
  13.17.3 Edenvridge Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.17.4 Edenvridge Main Business Overview
  13.17.5 Edenvridge Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Vaginosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vaginosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rx
Table 4. Major Players of OTC
Table 5. Global Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 6. Global Vaginosis Drug Sales Market Share by Type (2017-2022)
Table 7. Global Vaginosis Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vaginosis Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Vaginosis Drug Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 11. Global Vaginosis Drug Sales Market Share by Application (2017-2022)
Table 12. Global Vaginosis Drug Revenue by Application (2017-2022)
Table 13. Global Vaginosis Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Vaginosis Drug Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Vaginosis Drug Sales by Company (2020-2022) & (K Doses)
Table 16. Global Vaginosis Drug Sales Market Share by Company (2020-2022)
Table 17. Global Vaginosis Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vaginosis Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Vaginosis Drug Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Vaginosis Drug Producing Area Distribution and Sales Area
Table 21. Players Vaginosis Drug Products Offered
Table 22. Vaginosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaginosis Drug Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Vaginosis Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vaginosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vaginosis Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vaginosis Drug Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Vaginosis Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vaginosis Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vaginosis Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Vaginosis Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vaginosis Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Vaginosis Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Vaginosis Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Vaginosis Drug Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Vaginosis Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Vaginosis Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vaginosis Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Vaginosis Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Vaginosis Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Vaginosis Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vaginosis Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Vaginosis Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Vaginosis Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vaginosis Drug Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Vaginosis Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vaginosis Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vaginosis Drug Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Vaginosis Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vaginosis Drug Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Vaginosis Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vaginosis Drug
Table 66. Key Market Challenges & Risks of Vaginosis Drug
Table 67. Key Industry Trends of Vaginosis Drug
Table 68. Vaginosis Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vaginosis Drug Distributors List
Table 71. Vaginosis Drug Customer List
Table 72. Global Vaginosis Drug Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Vaginosis Drug Sales Market Forecast by Region
Table 74. Global Vaginosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vaginosis Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vaginosis Drug Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Vaginosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vaginosis Drug Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Vaginosis Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vaginosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vaginosis Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vaginosis Drug Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Vaginosis Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vaginosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vaginosis Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bayer Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Vaginosis Drug Product Offered
Table 94. Bayer Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Pfizer Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Vaginosis Drug Product Offered
Table 99. Pfizer Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Sanofi Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Vaginosis Drug Product Offered
Table 104. Sanofi Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Piramal Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Piramal Vaginosis Drug Product Offered
Table 109. Piramal Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 110. Piramal Main Business
Table 111. Piramal Latest Developments
Table 112. Abbott Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Abbott Vaginosis Drug Product Offered
Table 114. Abbott Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 115. Abbott Main Business
Table 116. Abbott Latest Developments
Table 117. Galderma Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Galderma Vaginosis Drug Product Offered
Table 119. Galderma Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 120. Galderma Main Business
Table 121. Galderma Latest Developments
Table 122. Mission Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Mission Vaginosis Drug Product Offered
Table 124. Mission Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 125. Mission Main Business
Table 126. Mission Latest Developments
Table 127. Alkem Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Alkem Vaginosis Drug Product Offered
Table 129. Alkem Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 130. Alkem Main Business
Table 131. Alkem Latest Developments
Table 132. Xiuzheng Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Xiuzheng Vaginosis Drug Product Offered
Table 134. Xiuzheng Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 135. Xiuzheng Main Business
Table 136. Xiuzheng Latest Developments
Table 137. Teva Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Teva Vaginosis Drug Product Offered
Table 139. Teva Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 140. Teva Main Business
Table 141. Teva Latest Developments
Table 142. Perrigo Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Perrigo Vaginosis Drug Product Offered
Table 144. Perrigo Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 145. Perrigo Main Business
Table 146. Perrigo Latest Developments
Table 147. West-Ward Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. West-Ward Vaginosis Drug Product Offered
Table 149. West-Ward Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 150. West-Ward Main Business
Table 151. West-Ward Latest Developments
Table 152. HPGC Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. HPGC Vaginosis Drug Product Offered
Table 154. HPGC Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 155. HPGC Main Business
Table 156. HPGC Latest Developments
Table 157. Yunnan Baiyao Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Yunnan Baiyao Vaginosis Drug Product Offered
Table 159. Yunnan Baiyao Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 160. Yunnan Baiyao Main Business
Table 161. Yunnan Baiyao Latest Developments
Table 162. Starpharma Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Starpharma Vaginosis Drug Product Offered
Table 164. Starpharma Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 165. Starpharma Main Business
Table 166. Starpharma Latest Developments
Table 167. Novel Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. Novel Vaginosis Drug Product Offered
Table 169. Novel Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 170. Novel Main Business
Table 171. Novel Latest Developments
Table 172. Edenvridge Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Edenvridge Vaginosis Drug Product Offered
Table 174. Edenvridge Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 175. Edenvridge Main Business
Table 176. Edenvridge Latest Developments

LIST OF FIGURES

Figure 1. Picture of Vaginosis Drug
Figure 2. Vaginosis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaginosis Drug Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Vaginosis Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vaginosis Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rx
Figure 10. Product Picture of OTC
Figure 11. Global Vaginosis Drug Sales Market Share by Type in 2021
Figure 12. Global Vaginosis Drug Revenue Market Share by Type (2017-2022)
Figure 13. Vaginosis Drug Consumed in Hospital
Figure 14. Global Vaginosis Drug Market: Hospital (2017-2022) & (K Doses)
Figure 15. Vaginosis Drug Consumed in Pharmacy
Figure 16. Global Vaginosis Drug Market: Pharmacy (2017-2022) & (K Doses)
Figure 17. Vaginosis Drug Consumed in Other
Figure 18. Global Vaginosis Drug Market: Other (2017-2022) & (K Doses)
Figure 19. Global Vaginosis Drug Sales Market Share by Application (2017-2022)
Figure 20. Global Vaginosis Drug Revenue Market Share by Application in 2021
Figure 21. Vaginosis Drug Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Vaginosis Drug Revenue Market Share by Company in 2021
Figure 23. Global Vaginosis Drug Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Vaginosis Drug Revenue Market Share by Geographic Region in 2021
Figure 25. Global Vaginosis Drug Sales Market Share by Region (2017-2022)
Figure 26. Global Vaginosis Drug Revenue Market Share by Country/Region in 2021
Figure 27. Americas Vaginosis Drug Sales 2017-2022 (K Doses)
Figure 28. Americas Vaginosis Drug Revenue 2017-2022 ($ Millions)
Figure 29. APAC Vaginosis Drug Sales 2017-2022 (K Doses)
Figure 30. APAC Vaginosis Drug Revenue 2017-2022 ($ Millions)
Figure 31. Europe Vaginosis Drug Sales 2017-2022 (K Doses)
Figure 32. Europe Vaginosis Drug Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Vaginosis Drug Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa Vaginosis Drug Revenue 2017-2022 ($ Millions)
Figure 35. Americas Vaginosis Drug Sales Market Share by Country in 2021
Figure 36. Americas Vaginosis Drug Revenue Market Share by Country in 2021
Figure 37. United States Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Vaginosis Drug Sales Market Share by Region in 2021
Figure 42. APAC Vaginosis Drug Revenue Market Share by Regions in 2021
Figure 43. China Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Vaginosis Drug Sales Market Share by Country in 2021
Figure 50. Europe Vaginosis Drug Revenue Market Share by Country in 2021
Figure 51. Germany Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Vaginosis Drug Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Vaginosis Drug Revenue Market Share by Country in 2021
Figure 58. Egypt Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Vaginosis Drug in 2021
Figure 64. Manufacturing Process Analysis of Vaginosis Drug
Figure 65. Industry Chain Structure of Vaginosis Drug
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


More Publications